Literature DB >> 3746638

Ocular pharmacokinetic models of clonidine-3H hydrochloride.

C H Chiang, R D Schoenwald.   

Abstract

A single topical instillation of clonidine-3H HCl solution (0.2%) was administered to the rabbit eye (30 microliter) in order to study the drug's ocular pharmacokinetics. Seven different tissues and plasma were excised and assayed for drug over 180 min. By 45-60 min pseudoequilibrium is reached for the cornea, iris/ciliary body, and aqueous humor. Thereafter, drug levels in these tissues decline in parallel. The data are fit separately to a physiological model and a classical diffusion model for which seven ocular tissue compartments and a plasma reservoir are constructed for each model. Clearance terms and distribution equilibrium coefficients are determined from the tissue level data and used as parameters in fitting the mass balance differential equations representing the physiological model. The model parameters can also be fit to a 0.4% single dose. In a separate experiment, a topical infusion technique was designed to provide a constant rate input to the cornea until an apparent steady state was reached in aqueous humor at 55 min. Aqueous humor levels were assayed for clonidine over the infusion and postinfusion periods. The physiological model parameters are fit to the topical infusion data and show good agreement between the predicted and experimental data. The classical model is too complex to fit the data to integrated exponential equations primarily because the method of residuals is inadequate in determining a sufficient set of initial estimates. This is overcome by dividing the eight-compartment model into seven fragmental models, each representing one to five compartments. A stepwise procedure is developed in which initial estimates are obtained for each separate fragmental model and refined. The refined parameter values can then be used as initial estimates for the complex model. Differential equations for the complex model are fit simultaneously to tissue levels representing each compartment. By observation, the classical model fit the data more closely than the physiological model. Statistical moment theory is also applied to the topical infusion data to determine ocular pharmacokinetic parameters for clonidine. The calculated values are: corneal absorption rate constant ka, 0.00139 min-1, aqueous humor elimination rate constant k10, 0.0658 min-1; mean residence time MRTd, 35.6 min; apparent steady-state volume of distribution Vss, 0.530 ml; and ocular clearance Qe, 14.9 microliter/min. The fraction absorbed from the single instillation is estimated as 0.0163.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3746638     DOI: 10.1007/bf01065260

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  24 in total

1.  Influence of topical anesthesia on tear dynamics and ocular drug bioavailability in albino rabbits.

Authors:  T F Patton; J R Robinson
Journal:  J Pharm Sci       Date:  1975-02       Impact factor: 3.534

2.  Altered bioavailability of drugs in the eye due to drug-protein interaction.

Authors:  T J Mikkelson; S S Chrai; J R Robinson
Journal:  J Pharm Sci       Date:  1973-10       Impact factor: 3.534

3.  Corneal penetration behavior of beta-blocking agents I: Physiochemical factors.

Authors:  R D Schoenwald; H S Huang
Journal:  J Pharm Sci       Date:  1983-11       Impact factor: 3.534

4.  Topical carbonic anhydrase inhibitors IV: Relationship between excised corneal permeability and pharmacokinetic factors.

Authors:  M G Eller; R D Schoenwald; J A Dixson; T Segarra; C F Barfknecht
Journal:  J Pharm Sci       Date:  1985-05       Impact factor: 3.534

5.  Penetration routes of topically applied eye medications.

Authors:  M G Doane; A D Jensen; C H Dohlman
Journal:  Am J Ophthalmol       Date:  1978-03       Impact factor: 5.258

6.  Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits.

Authors:  V H Lee; J R Robinson
Journal:  J Pharm Sci       Date:  1979-06       Impact factor: 3.534

7.  Aqueous chamber drug distribution volume measurement in rabbits.

Authors:  J M Conrad; J R Robinson
Journal:  J Pharm Sci       Date:  1977-02       Impact factor: 3.534

8.  Ocular and systemic bioavailability of ophthalmic flurbiprofen.

Authors:  D D Tang-Liu; S S Liu; R J Weinkam
Journal:  J Pharmacokinet Biopharm       Date:  1984-12

9.  Pharmacokinetics of topical ocular phenylephrine HCl.

Authors:  M E Antoine; H F Edelhauser; W J O'Brien
Journal:  Invest Ophthalmol Vis Sci       Date:  1984-01       Impact factor: 4.799

10.  Relationship of chemical structure to corneal penetration and influence of low-viscosity solution on ocular bioavailability.

Authors:  G M Grass; J R Robinson
Journal:  J Pharm Sci       Date:  1984-08       Impact factor: 3.534

View more
  10 in total

1.  Role of P-glycoprotein in ocular clearance of rhodamine 123 in rabbits.

Authors:  T Kajikawa; H K Mishima; T Murakami; M Takano
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

2.  Biopharmaceutical evaluation of ibufenac, ibuprofen, and their hydroxyethoxy analogs in the rabbit eye.

Authors:  C S Rao; R D Schoenwald; C F Barfknecht; S L Laban
Journal:  J Pharmacokinet Biopharm       Date:  1992-08

3.  Prediction of the corneal permeability of drug-like compounds.

Authors:  Heidi Kidron; Kati-Sisko Vellonen; Eva M del Amo; Anita Tissari; Arto Urtti
Journal:  Pharm Res       Date:  2010-04-13       Impact factor: 4.200

4.  Effect of pH and formulation variables on in vitro transcorneal permeability of flurbiprofen: a technical note.

Authors:  Sajeev Chandran; Archna Roy; Ranendra N Saha
Journal:  AAPS PharmSciTech       Date:  2008-09-16       Impact factor: 3.246

Review 5.  Ocular drug delivery. Pharmacokinetic considerations.

Authors:  R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

6.  Corneal Anesthesia With Site 1 Sodium Channel Blockers and Dexmedetomidine.

Authors:  James Brian McAlvin; Changyou Zhan; Jenny C Dohlman; Paraskevi E Kolovou; Borja Salvador-Culla; Daniel S Kohane
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

7.  Effect of norfloxacin and clonidine on human trabecular meshwork cells in vitro.

Authors:  Q Wang; H Wei; Z Fan; Y Lu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-09       Impact factor: 3.117

8.  In vitro and in vivo evaluation in rabbits of a controlled release 5-fluorouracil subconjunctival implant based on poly(D,L-lactide-co-glycolide).

Authors:  G Wang; I G Tucker; M S Roberts; L W Hirst
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

9.  Ocular pharmacokinetics and pharmacodynamics of phenylephrine and phenylephrine oxazolidine in rabbit eyes.

Authors:  D S Chien; R D Schoenwald
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

Review 10.  Nanotechnology for Medical and Surgical Glaucoma Therapy-A Review.

Authors:  Marcelo Luís Occhiutto; Raul C Maranhão; Vital Paulino Costa; Anastasios G Konstas
Journal:  Adv Ther       Date:  2019-12-10       Impact factor: 3.845

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.